Walensky strives to put CDC messaging back on track — States’ vaccine prizes fizzle — With Obamacare safe, new battles begin

From: POLITICO Pulse - Monday Jun 21,2021 03:08 pm
Presented by PhRMA: Delivered daily by 10 a.m., Pulse examines the latest news in health care politics and policy.
Jun 21, 2021 View in browser
 
POLITICO's Pulse newsletter logo

By Sarah Owermohle and Adam Cancryn

Presented by

PhRMA

With Daniel Lippman

Editor’s Note: POLITICO Pulse is a free version of POLITICO Pro Health Care's morning newsletter, which is delivered to our s each morning at 6 a.m. The POLITICO Pro platform combines the news you need with tools you can use to take action on the day’s biggest stories. Act on the news with POLITICO Pro.

Driving the day

— Limited press, tricky policy rollouts: CDC Director Rochelle Walensky is struggling to present a clear and unified message at her beleaguered agency.

— Lotteries and prizes to encourage Covid-19 vaccination haven’t made a sustained difference in vaccine administration rates, according to a POLITICO analysis.

— Now that Republicans’ legal challenges to Obamacare seem to be exhausted, Democrats must reckon with their other health care priorities.

WELCOME TO MONDAY PULSEHappy belated Father’s Day to all and especially Pulse’s dads, wonderful men who helped raise driven journalists with weird sleep patterns. Tell us how you celebrated and send tips to sowermohle@politico.com and acancryn@politico.com.

 

A message from PhRMA:

The way insurance covers your medicine is too complicated. See how we can make the system work for patients. Not the other way around.

 
Driving the day

WALENSKY STRIVES TO PUT CDC BACK ON TRACKAfter a brutal year, the agency now faces what could be its biggest test yet: loosening coronavirus guidance while trying to tamp down new outbreaks in undervaccinated communities. That’s meant Walensky has had t o unify the agency’s public messaging, Erin Banco writes.

While she regularly appears on national TV and in White House press briefings, Walensky’s top lieutenants and the CDC’s rank-and-file scientists rarely make public appearances or give interviews to journalists. That lack of media access pushed the Washington, D.C., chapter of the Society of Professional Journalists in February to send her a letter, denouncing the CDC's “restrictions on staff speaking to reporters without notifying authorities.”

Yet the CDC’s strategy for rolling out new Covid guidance has still caused some headaches in the administration. The agency in March stalled on officially releasing its recommendations for vaccinated Americans — even after the guidelines had been circulating among top officials and some reporters. When the CDC updated that guidance in April, it again caught some officials off-guard, Erin writes.

Still, Walensky’s colleagues at the CDC say they are still hopeful she will lead the agency into a new, more positive era. “So many of the changes that [Walensky] is making are long overdue,” said a senior CDC official. The CDC did not respond to a request for comment on Erin’s story.

GLITZY VACCINE SWEEPSTAKES FAIL TO CUT THROUGH APATHY — States’ efforts to boost Covid-19 vaccination rates through million-dollar lotteries have not reversed a steep decline in adult coronavirus vaccinations, according to a POLITICO analysis of federal data by Dan Goldberg and Tucker Doherty.

Ohio — which promised $1 million to five lucky adults, the first state to offer such a giveaway — saw a two-week bump in adult vaccination rates last month. But the pace of vaccinations there has already fallen off, and despite the lottery bump, the state continues to lag behind the national average in the share of adults given a first dose. Other states that followed Ohio’s example have only seen marginal gains, the analysis shows.

“People aren’t buying it,” said Irwin Redlener, who directs the Pandemic Resource and Response Initiative at Columbia University. “The incentives don’t seem to be working — whether it’s a doughnut, a car or a million dollars.”

Why? State lotteries and giveaways appear to offer diminishing returns in part because the so-called movable middle — the group that is willing but not persuaded to get vaccinated — gets smaller and smaller every day, Dan and Tucker write. But public health officials say they’ll try almost anything to get shots in arms.

ICYMI: WITH OBAMACARE SAFE, A NEW BATTLE BEGINS — The Supreme Court’s decision Thursday dealt the final blow to GOP dreams of repealing the Affordable Care Act; now, Democrats must reckon with the future of their health care vision, Susannah Luthi writes.

Even the ACA’s biggest fans acknowledge Obamacare has its problems: high premiums, large deductibles, and a gaping coverage gap in the dozen, mostly Republican, states that still refuse to expand Medicaid. But Obamacare’s future could look very different depending on Democratic leaders’ next steps.

“For many years, one of the biggest obstacles to making big progressive steps on health care was the mantra that we needed to implement Obamacare and then defend Obamacare,” said Adam Green, co-founder of the Progressive Change Campaign Committee. “It was a very existential block to going forward, just keeping the law alive. Now that it seems quite safe, there’s more flexibility across the Democratic Party to take bold steps.”

President Joe Biden campaigned on making seismic changes to the ACA, such as offering a public option and lowering the Medicare age to 60, but has since pulled back to focus on more incremental policies. The Democrats’ Covid relief package in March temporarily boosted Obamacare subsidies by nearly 30 percent, which the president is looking to make permanent.

 

DON'T MISS THE MILKEN INSTITUTE FUTURE OF HEALTH SUMMIT: POLITICO will feature a special edition of our Future Pulse newsletter at the 2021 Milken Institute Future of Health Summit. The newsletter takes readers inside one of the most influential gatherings of global health industry leaders and innovators who are turning lessons learned from the past year into a healthier, more resilient and more equitable future. Covid-19 threatened our health and well-being, while simultaneously leading to extraordinary coordination to improve pandemic preparedness, disease prevention, diversity in clinical trials, mental health resources, food access and more. SUBSCRIBE TODAY to receive exclusive coverage from June 22-24.

 
 


Coronavirus

WITH 300M MARK, BIDEN ISSUES WARNING — Biden on Friday marked a milestone for coronavirus vaccinations with a stark warning about the dangers of a new Covid-19 variant now spreading in the U.S.

“People getting seriously ill and being hospitalized due to Covid-19 are those who have not been fully vaccinated,” Biden said. “[The Delta variant] is a variant that is more easily transmissible, potentially deadlier, and particularly dangerous for young people.”

As of Friday, 65.1 percent of American adults have received at least one dose of a Covid vaccine, Ben Leonard reports. But some states, especially in the South, are still lagging behind that national rate. Data has shown a partisan gap in vaccinations, with Republican districts far less likely to have hit 60 percent of residents vaccinated.

Preparing for the worst: Walensky said Friday on “Good Morning America” that the Delta variant will "probably" become the dominant strain in the U.S. in the coming months. This variant, which first appeared in India, appears to be 40 to 80 percent more transmissible and about twice as likely to cause hospitalization as the Alpha variant, another highly transmissible strain first found in the U.K.

 

Advertisement Image

 
Around the Agencies

CDC VACCINE MEETING THIS WEEK — A CDC advisory panel will meet Wednesday to discuss vaccine safety, after Friday’s meeting was postponed in observation of Juneteenth, now a federal holiday.

The committee was expected to receive an update on heart health risks for patients who have been vaccinated with mRNA Covid shots (those made by Pfizer and Moderna) particularly younger men. A discussion of booster shots is also on the agenda, Lauren Gardner writes.

ICYMI: MANCHIN SAYS WOODCOCK ‘NOT RIGHT' FOR FDA — Sen. Joe Manchin took his most public stance yet against making acting FDA commissioner Janet Woodcock the agency's permanent chief, Lauren reported Thursday.

Citing both the opioid epidemic — especially acute in his state — and FDA's recent approval of a controversial Alzheimer's drug, Biogen’s Aduhelm, the moderate West Virginia Democrat urged the White House to look elsewhere.

"Having a permanent agency head in charge to answer patients’ and doctors’ questions on this approval, as well as assure the general public of the FDA’s commitment to public health, is imperative, and Dr. Woodcock is not the right person to lead the FDA," he wrote. “Without a permanent, confirmed commissioner in place to lead the FDA, important decisions that impact the country’s response to COVID-19 will be slowed and prevent additional work to combat the ongoing drug overdose epidemic.”

 

TUNE IN TO DISPATCH+ ON APPLE PODCASTS : POLITICO Dispatch, our daily podcast that cuts through the news clutter and keeps you up to speed on the most important developments of the moment, is expanding. In collaboration with the new Apple Podcasts Subscription platform, Dispatch+ launches this week! This new podcast gives premium Dispatch+ s exclusive bonus weekly reporting and analysis from POLITICO's newsroom. Don't miss out, subscribe and listen to Dispatch+ on Apple Podcasts.

 
 


Names in the News

Christi Grimm is the new HHS inspector general. Grimm has been with the IG office for 22 years and overseen efforts to assess the government’s response to the Covid-19 pandemic, the White House said.

Adaeze Enekwechi and Lucia Savage are joining Evidation Health as advisors. Both are former government officials: Enekwechi was associate director of health programs in Obama’s budget office while Savage was the chief privacy officer in HHS’s Health IT department.

Mary Beth Donahue will be Better Medicare Alliance’s president and CEO, succeeding Allyson Schwartz, the former congresswoman who has led BMA since its founding. Donahue most recently was executive director of Kidney Care Partners.

Former Surgeon General Jerome Adams will be a medical expert for Indiana’s WISH-TV.

Tony Jewell is now executive director at Neurocrine Biosciences. He most recently was the founder of Boardwalk Public Relations and is also a George W. Bush-era HHS alum.

 

A message from PhRMA:

Getting to what you pay for medicines shouldn’t be a maze. Let’s make out-of-pocket costs transparent, predictable and affordable. And let’s do it without sacrificing access to medicines and innovation. See how we can make the system work for patients. Not the other way around.

 
What We're Reading

Discussion about “gain-of-function” research has gained traction in recent weeks, stoking conversations about how scientists should study future pathogens, write Carl Zimmer and James Gorman in the New York Times.

Anthony Fauci and D.C. Mayor Muriel Bowser went door-to-door in Anacostia this weekend to talk with people about getting Covid-19 shots, sometimes with mixed results, reports the Washington Post’s Julie Zauzmer.

In a Colorado county with lagging vaccination rates, cases of the Delta variant and hospitalizations from Covid-19 are rising, Seth Klamann reports in The Gazette.

 

Follow us on Twitter

Joanne Kenen @joannekenen

Adriel Bettelheim @abettel

Jason Millman @jasonmillman

Lauren Morello @lmorello_dc

Sara Smith @sarasmarley

Adam Cancryn @adamcancryn

Tucker Doherty @tucker_doherty

Dan Goldberg @dancgoldberg

David Lim @davidalim

Susannah Luthi @SusannahLuthi

Alice Miranda Ollstein @aliceollstein

Sarah Owermohle @owermohle

Carmen Paun @carmenpaun

Rachel Roubein @rachel_roubein

Darius Tahir @dariustahir

Erin Banco @ErinBanco

Lauren Gardner @Gardner_LM

Katherine Ellen Foley @katherineefoley

 

Follow us

Follow us on Facebook Follow us on Twitter Follow us on Instagram Listen on Apple Podcast
 

To change your alert settings, please log in at https://www.politico.com/_login?base=https%3A%2F%2Fwww.politico.com/settings

This email was sent to by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA

Please click here and follow the steps to .

More emails from POLITICO Pulse